R&D
Why the future of eSource starts with the research site
Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.
Market Access
Biotech funding has returned. The bar has moved with it.
For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.
Oncology
Building a Phase I oncology centre
The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.
Patients
The strategic opportunity: Owning the behaviour layer
Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.
Sales & Marketing
Media Partner
Why BIO-Europe 2026 matters: The evolution of strategic biop...
2026 marks a significant evolution for BIO-Europe.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
